North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for around 32% market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskeletal disorders. Western Europe was the second largest region accounting for around 22.5% market share. Asia Pacific was the third largest region accounting for around 22% market share.
Musculoskeletal Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal drugs sector.
Reasons to Purchase
Fully updated for 2018.
Identify growth segments and opportunities.
Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
Develop strategies based on likely future developments.
Gain a global perspective on the development of the market.
Musculoskeletal Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the musculoskeletal drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the musculoskeletal drugs market and suggests approaches.
Markets Covered: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others.
Companies Mentioned: F. Hoffmann-La Roche Ltd., GlaxosmithKline Plc., Pfizer Inc., Daiichi Sankyo Company Limited, Abbott Laboratories Inc., Johnson & Johnson, Sanofi S.A., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Celgene Corporation
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.